{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-028170","form_type":"8-K","ticker":"WINT","cik":"0000946486","company_name":"WINDTREE THERAPEUTICS INC /DE/","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.752658+00:00","generated_at":"2026-05-17T09:08:11.128951+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Windtree shareholders approve 1:2-1:25 reverse split, 8x authorized share increase, all 9 proposals","bullets":["All 9 proposals passed at Aug 28 special meeting; majority of votes cast in favor.","Authorized shares increased to 1B from 125M (Proposal 7: 9.5M For, 1.2M Against).","Reverse stock split ratio of 1:2 to 1:25 approved; board has discretion on exact ratio and timing.","Shareholders approved issuances of common shares upon conversion of Series D, E preferred, notes, warrants, and ELOC.","2020 Equity Incentive Plan amended to reserve additional 2.6M shares for issuance."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-028170","json":"https://secwatch.observer/filing/0001437749-25-028170.json","markdown":"https://secwatch.observer/filing/0001437749-25-028170.md","text":"https://secwatch.observer/filing/0001437749-25-028170.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946486/000143774925028170/0001437749-25-028170-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946486/000143774925028170/wint20250902_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:08:11.128951+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}